FDA Updates for the Week of April 18, 2022
April 23rd 2022The FDA has approved a generic of Zavesca for Gaucher disease and has accepted applications for a supplement indication for Enhertu and a novel therapy for CKD-related anemia. The regulatory agency also issued a CRL for Teva’s schizophrenia drug.
Read More
Tezspire Misses Primary End Point in SOURCE, but Provides Other Benefits for Patients With Asthma
April 22nd 2022Despite missing the primary end point of significantly reducing oral corticosteroid dose, patients with asthma on Tezspire in the SOURCE trial received other benefits from the drug.
Read More
Enterprise Imaging: A Necessity – Not a Luxury – for Hospitals & Health Systems
April 22nd 2022Enterprise imaging platforms would enable organizations to consistently and optimally capture, index, manage, store, distribute, view, exchange and analyze all clinical imaging and multimedia content, enhancing patients’ electronic health records.
Read More
As of early this year, as many as 23 million Americans may have developed long COVID, in which symptoms persist four or more weeks after first being infected with the virus. The condition is likely to have additional long-term effects that are not yet clear. However, the U.S. has begun to obtain a glimpse of long COVID’s far-reaching impact on those who suffer from it - and the picture is rather disturbing.
Read More
CDC’s Proposed Opioid Prescribing Guideline: Does it Fall Short on Drug Testing?
April 18th 2022Last month, the Centers for Disease Control and Prevention shared a draft update to its Clinical Practice Guideline for Prescribing Opioids. The proposed revision comes as the nation’s overdose death rate reaches an all-time high, fueled largely by the economic and psychological strains and lack of healthcare access caused by COVID-19.
Read More
In this week's episode, Briana Contreras, editor of Managed Healthcare Executive, spoke with Dr. Paige Kilian, chief medical officer at Inovalon. In the discussion, Dr. Kilian broke down the current issues health plans are facing when it comes to risk adjustment and how it’s affecting members of these plans. She also shared some solutions that can help plans improve risk adjustment and quality programs with one in particular being health plans identifying care gaps through data and analytics.
Listen
5 Exacerbation-prone Phenotypes Were Discovered Among Asthma and COPD Patients
April 14th 2022Five phenotype clusters were discovered to be associated with the exacerbation, or worsening, of chronic inflammatory airway diseases of asthma and chronic obstructive pulmonary disease (COPD), according to a recent study published in PLOS ONE.
Read More
More Evidence of Mental Health Services Shifting to Telehealth: Health Affairs Study
April 13th 2022Findings published in the April issue of Health Affairs show a huge jump in telehealth visits, but the researchers also detected that a pattern that suggests that people with conditions such as schizophrenia did not make the switch to telehealth as readily as people with anxiety and some other disorders.
Read More
Finding a Way Forward for Public Health - Greater Investment, Greater Distrust
April 13th 2022“The most remarkable change in patterns of health during the (past) century has been the largely successful conquest of infectious diseases,” wrote Allan Brandt, Harvard medical historian, in “No Magic Bullet: A Social History of Venereal Disease in the United States Since 1880."
Read More